Neurologic Events




Central Nervous System Injury


Definition


A central nervous system (CNS) injury is any new neurologic deficit presenting after anesthesia that can be localized anatomically to the brain or spinal cord.


Etiology





  • Cerebral ischemia




    • Global



    • Focal




  • Cerebral hemorrhage



  • Cerebral embolism



  • Increased ICP



  • Hypoglycemia



  • Direct trauma or surgical injury to CNS



  • Injection of neurolytic solutions into the cerebrospinal fluid or into CNS



  • Epidural or subdural hematoma



Typical Situations





  • In patients with diseases predisposing to cerebral ischemia or embolism




    • AF



    • Endocardial mural thrombus following a MI



    • Known cerebrovascular disease




      • Previous stroke or transient ischemic attacks (TIAs)



      • Hypertension



      • Smoking history



      • Diabetes mellitus



      • Dyslipidemia



      • Obesity




    • Pregnancy-induced hypertension




  • Following surgery that carries a high risk of CNS injury




    • Carotid endarterectomy or carotid stenting



    • Procedures requiring CPB




      • Cardiac surgery



      • Repair of descending thoracic aneurysm or dissection (impaired blood flow to the spinal cord)




    • Craniotomy or procedures on or near the spinal cord




  • Following an intraoperative catastrophe with hypotension or cardiac arrest



  • In patients with raised ICP



  • In patients positioned with traction on or compromise of blood flow to the spinal cord




    • Procedures in the sitting position




  • In patients with anatomic abnormalities of the bony covering of the CNS




    • Congenital (Down syndrome, Klippel-Feil syndrome)



    • Acquired (rheumatoid arthritis with cervical instability)



    • Spinal stenosis




  • Following neuraxial anesthesia (especially in patients taking anticoagulants and antiplatelet agents)



Prevention





  • Identify patients with conditions that predispose to CNS injury




    • Optimize treatment of medical conditions (hypertension, diabetes mellitus)



    • Monitor neurologic function in patients at risk




      • EEG



      • Evoked potentials





  • Position patients carefully and reassess during long cases




    • Avoid extreme rotation, flexion, or extension of the cervical spine



    • In the sitting position, support patients adequately to prevent traction on the spinal cord or cervical spine




  • Maintain an adequate cerebral perfusion pressure




    • Measure BP at the level of the brain




  • Maintain adequate perfusion pressure of the spinal cord




    • Consider placement of a lumbar drain during thoracic aortic surgery




  • In patients with raised ICP




    • Avoid obstruction to cerebral venous outflow



    • Maintain the head in an elevated position



    • Ventilate the patient to maintain PaCO 2 of 30 to 35 mm Hg




  • Avoid neuraxial regional anesthesia in patients with a bleeding diathesis



Manifestations





  • Cerebral injuries may be manifested by




    • Delayed recovery from anesthesia



    • A new focal motor or sensory deficit



    • Seizures



    • Subarachnoid hemorrhage




      • Severe headache, stiff neck, or neurologic deficit





  • SCI may be manifested by




    • Failure of the sensory or motor level to recede after neuraxial block



    • Motor and/or sensory deficits



    • Cauda equina syndrome




      • Loss of bowel and/or bladder function, saddle anesthesia, lower extremity pain and/or weakness





Similar Events





Management





  • Ensure adequate oxygenation and ventilation (see Event 10, Hypoxemia , and Event 32, Hypercarbia )




    • Mild hypoxemia can cause obtundation but more often causes restlessness, which may be mistakenly treated with further sedation and result in respiratory depression



    • Severe hypoxemia can cause coma



    • Hypercarbia generally causes obtundation




  • Check that all volatile and IV anesthetics have been discontinued




    • Administer 100% O 2 with high flows into the breathing circuit to enhance elimination of inhalation anesthetics



    • Check expired anesthetic gas concentrations




  • Stimulate the obtunded patient




    • Use verbal or tactile stimuli and gentle suctioning of the upper airway




  • Perform a neurologic examination




    • Check pupillary diameter and reaction to light




      • Anesthetic or ophthalmic drugs may affect pupillary size or response to light




    • CNS injury may alter pupillary size or might manifest as a blown pupil



    • Check for the presence of corneal and gag reflexes



    • Test the response to physical stimulation or deep pain



    • Check the limb reflexes and plantar responses (Babinski reflex)




  • If abnormalities on neurologic examination are evident, inform the surgeon




    • Assume cerebral ischemia, infarction, embolism, or hemorrhage has occurred



    • Obtain an immediate neurology or neurosurgery consultation



    • Obtain a CT scan of the head or spinal cord if the patient can be moved safely




      • Hypertension and hypotension should be managed cautiously in consultation with the neurologist




    • Other imaging studies may be needed to determine cause of abnormality



    • Further therapy depends on the diagnosis but may include




      • Thrombolytics or anticoagulation for cerebral thromboembolism



      • Surgical decompression of intracranial hemorrhage



      • External ventricular drain placement for ICP management




    • For acute, nonpenetrating SCI, consider administering high-dose corticosteroids




      • Methylprednisolone IV, 30 mg/kg, followed by 5.4 mg/kg/day for 24 or 48 hours



      • Use of steroids in acute SCI remains controversial





  • Rule out a metabolic etiology





  • Send urine or blood for toxicology screens



  • Check for drug administration errors (see Event 63, Drug Administration Error )



Complications





  • Hypoxemia, hypercarbia



  • Cardiovascular instability



  • Inability to maintain or protect the airway



  • Aspiration of gastric contents



  • Extension of neurologic injury



  • Permanent CNS injury



  • Metabolic abnormalities (e.g., hyperglycemia)



  • Seizures



  • Death



Suggested Reading


  • 1. Stahel P.F., VanderHeiden T., Finn M.A.: Management strategies for acute spinal cord injury: current options and future perspectives. Curr Opin Crit Care 2012; 18: pp. 651-660.
  • 2. Mashour G.A., Shanks A.M., Kheterpal S.: Perioperative stroke and associated mortality after noncardiac, nonneurologic surgery. Anesthesiology 2011; 114: pp. 1289-1296.
  • 3. Davis M.J., Menon B.K., Baghirzada L.B., et. al.: Anesthetic management and outcome in patients during endovascular therapy for acute stroke. Anesthesiology 2012; 116: pp. 396-405.



  • Local Anesthetic Systemic Toxicity


    Definition


    Local anesthetic systemic toxicity (LAST) is an adverse systemic effect of high blood concentrations of local anesthetics.


    Etiology





    • Direct intravascular injection of local anesthetic solution



    • Excessive amount of local anesthetic absorbed into the circulation over a short period



    Typical Situations





    • During regional anesthesia in which large volumes of local anesthetic are administered or when there is significant potential for intravascular injection




      • Epidural anesthesia



      • Intercostal nerve blocks



      • Paravertebral block



      • Lumbar plexus block



      • Brachial plexus block



      • Femoral nerve block



      • Paracervical block for gynecologic procedures



      • IV regional anesthesia (Bier block)



      • Pain-related blocks (e.g., stellate ganglion block, lumbar sympathetic block, etc.)




    • During IV lidocaine infusion



    • During topicalization of the nasopharynx with local anesthetic



    Prevention





    • Create “LAST Treatment Kit” and notify personnel as to its contents and location



    • Post a LAST treatment cognitive aid at locations where high volumes and concentrations of local anesthetics are used (e.g., block areas, ORs, PACUs, labor and delivery)



    • Pretreating the patient with a benzodiazepine will increase the seizure threshold but may mask early LAST neurologic symptoms



    • Where large volumes of local anesthetic are administered, use standard American Society of Anesthesiologists (ASA) monitoring during and after the block for 30 minutes



    • Use the following techniques during regional blockade to minimize risk of intravascular injection:




      • Ultrasound guidance



      • Assess the patient’s response to a test dose of local anesthetic; consider using epinephrine (5 µg/mL) as a marker for intravascular injection



      • Use an incremental aspiration and injection technique, looking for blood prior to injecting local anesthetic



      • Continuously assess patient’s mental, neurologic, and cardiovascular status during and after block



      • Any abnormality in patient status should be considered LAST until proven otherwise



      • Use the least amount of local anesthetic for desired effect



      • Do not administer more than the maximum recommended dose




    • Monitor the surgeon’s use of local anesthetic for infiltration and in surgical packing



    • Use appropriate bolus doses and infusion rates for IV lidocaine therapy




      • Check blood lidocaine levels during prolonged infusions




    Manifestations





    • CNS abnormalities




      • Tinnitus



      • Circumoral numbness, heavy tongue, metallic taste



      • Nystagmus, diplopia, difficulty in focusing



      • Mental status change: agitation, confusion, obtundation, coma



      • Preseizure motor irritability (twitching), followed by overt seizure




    • Airway and respiratory abnormalities




      • Airway obstruction



      • Loss of airway reflexes



      • Respiratory depression followed by apnea




    • Cardiovascular abnormalities




      • Initially may be hyperdynamic (hypertension, tachycardia, ventricular arrhythmias)



      • Conduction abnormalities (e.g., increased PR interval, T wave changes, bradycardia, asystole)



      • Progressive hypotension



      • Ventricular arrhythmias (VT, VF, torsades de pointes)



      • Cardiovascular collapse—cardiac arrest




        • Bupivacaine is the local anesthetic most likely to produce cardiovascular collapse, as the cardiovascular collapse:convulsion dosage ratio is lower for bupivacaine than for other local anesthetics



        • Patients with low cardiac ejection fraction are more susceptible to the cardiotoxic effects of local anesthetics



        • Acidosis and hypoxemia markedly potentiate the cardiotoxicity of bupivacaine





    Similar Events





    Management


    Intra-arterial injection into the carotid or vertebral arteries will result in immediate CNS toxicity, even with small volumes of local anesthetic.




    • Stop injection of local anesthetic at the first indication of toxicity



    • Call for help, get LAST Treatment Kit, and use the cognitive aid




      • Severe cases of LAST may require prolonged treatment



      • Patients who are healthy at the initiation of the event usually can be resuscitated




    • If respiratory distress, apnea, or loss of consciousness occurs




      • Establish bag valve mask airway



      • Deliver 100% O 2 , assist ventilation as necessary



      • Do not hyperventilate the patient, as this decreases the seizure threshold, but ensure adequate ventilation, as hypercapnia and hypoxemia exacerbate toxicity




    • Ensure adequate IV access



    • If there is preseizure motor irritability or seizure activity




      • Administer




        • Midazolam IV, 0.5 to 1 mg increments



        • Propofol IV, 10 to 20 mg (higher doses can further depress cardiac function)




          • Seizures are often exquisitely sensitive to these drugs






    • If seizures occur, cardiovascular collapse may be imminent




      • Immediately administer lipid emulsion (20%)




        • Bolus 1.5 mL/kg over 1 minute (approximately 100 mL)



        • Continuous infusion 0.25-0.5 mL/kg/min until stable



        • Can repeat bolus dose if symptoms persist or if progresses to cardiac arrest



        • Recommended upper limit: 10 mL/kg in first 30 minutes



        • Continue infusion for at least 10 minutes after attaining circulatory stability





    • If seizures do not resolve rapidly




      • Intubate the patient’s trachea using a short-acting muscle relaxant



      • Administer higher doses of midazolam



      • Administer other anticonvulsant drugs (see Event 57, Seizures )




        • Phenytoin IV, loading dose, 10 mg/kg, administered slowly (may cause hypotension)



        • Levetiracetam IV, 1000 mg




      • Administer muscle relaxant after the airway is protected to minimize peripheral O 2 consumption and resultant acidosis during seizures




        • Assess ongoing seizure activity using an EEG monitoring device





    • Management of Cardiac Instability




      • If patient arrests




        • Prolonged resuscitation efforts may be necessary



        • CPR as per BLS/ACLS with these modifications (see Event 94, Cardiac Arrest , and Event 82, Cardiac Arrest in the Parturient )



        • Medications:




          • Reduce epinephrine doses to < 1 μg/kg initially; high-dose epinephrine (1 mg) might impair resuscitation and efficacy of lipid rescue



          • Administer lipid emulsion (20%) as stated previously



          • AVOID vasopressin, calcium channel blockers, beta blockers, local anesthetics, and higher doses of propofol



          • Consider CPB for refractory cardiac arrest




            • Notify the necessary personnel (cardiac surgeon, perfusionist)



            • Transferring any patient in cardiac arrest within a hospital is VERY difficult; consider initiation of CPB at the location where the cardiac arrest occurred



            • If CPB is not available, alert the nearest facility with CPB capability and arrange transfer of the patient







    • Monitor patient in the ICU for at least 12 hours, as LAST can persist or recur after initial treatment



    • Obtain a consultation from a neurologist if seizures do not resolve



    Complications





    • Cardiovascular collapse



    • Hypoxic brain injury



    • Status epilepticus



    • Recurrence of systemic toxicity



    • Aspiration



    • Death



    NOTE: Infusion of lipid emulsion has proved useful in the treatment of overdose of other lipid-soluble medications (tricyclic antidepressants and sodium channel blockers). Consider the use of lipid emulsion where overdose is a possibility.


    Suggested Reading


  • 1. Neal J.M., Bernards C.M., Butterworth J.F., et. al.: ASRA practice advisory on local anesthetic systemic toxicity. Reg Anesth Pain Med 2010; 35: pp. 152-161.
  • 2. Neal J.M., Mulroy M.F., Weinberg G.L.: American Society of Regional Anesthesia and Pain medicine checklist for managing local anesthetic systemic toxicity: 2012 version. Reg Anesth Pain Med 2012; 37: pp. 16-18.
  • 3. Neal J.M., Hsiung R.L., Mulroy M.F., et. al.: ASRA checklist improves trainee performance during a simulated episode of local anesthetic systemic toxicity. Reg Anesth Pain Med 2012; 37: pp. 8-15.
  • 4. Wolfe J.W., Butterworth J.F.: Local anesthetic systemic toxicity: update on mechanisms and treatment. Curr Opin Anesth 2011; 24: pp. 561-566.
  • 5. Mercado P., Weinberg G.L.: Local anesthetic systemic toxicity: prevention and treatment. Anesthesiol Clin 2011; 29: pp. 233-242.



  • Perioperative Visual Loss


    Definition


    Perioperative visual loss (POVL) is permanent, partial, or total loss of vision during or after general anesthesia.


    Etiology





    • Ischemic optic neuropathy (ION)




      • Anterior ION



      • Posterior ION




    • Central retinal artery occlusion (CRAO)



    • Direct mechanical trauma to optic nerve or compression from retrobulbar hematoma (e.g., during sinus surgery)



    • Retinal arterial or venous hemorrhages involving the macula or leading to optic nerve atrophy



    • Acute closed-angle glaucoma



    • Cortical blindness



    • Photic injury from laser techniques



    • Direct ocular trauma



    Typical Situations





    • Prolonged spine or other surgery in the prone position



    • Procedures with substantial blood loss or hypotension



    • Procedures performed in the steep Trendelenburg position (e.g., robotic prostatectomy or robotic gynecology cases)



    • Perioperative globe compression



    • Procedures requiring CPB



    • Retrobulbar or peribulbar block administration



    • Male gender



    • Obesity



    Prevention


    Not all of the causative factors in POVL are known, the following are based on current recommendations.




    • Consider “staging” long, complex spine procedures as two or more separate operations



    • Maintain head in neutral position




      • Avoid head below heart position



      • Avoid use of Wilson positioning frame




    • Maintain BP within 20% of baseline



    • Avoid deliberate hypotension



    • Avoid hemodilution




      • Balance crystalloid administration with colloid



      • Monitor hematocrit at frequent intervals




        • Discuss transfusion threshold with patient and surgeon





    • Avoid direct pressure on globe and reassess at frequent intervals




      • Consider using mirrored headrest in prone cases




    • Avoid prolonged CPB times



    • Avoid N 2 O during and after intraocular sulfur hexafluoride (e.g., surgery for detached retina)



    • Cover patient’s eyes with appropriate goggles during nonocular laser surgery



    • Monitor visual-evoked potentials in procedures that affect the ophthalmic artery or optic nerve



    Manifestations





    • Loss of vision evident after recovery from anesthesia




      • Bilateral or unilateral



      • Partial or total




    • Periorbital edema and chemosis



    • Decreased ocular movements



    • Nystagmus



    • Ocular pain



    • Abnormal fundoscopic examination



    • Loss of or abnormal pupillary reflexes



    • CRAO




      • Unilateral vision loss or changes in light perception, decreased extraocular movements



      • Periorbital edema and chemosis



      • Cherry-red spot and pale, edematous retina on fundoscopic examination



      • Afferent pupillary defect




    • Anterior ION




      • Painless visual loss



      • MRI evidence of enlarged optic nerve



      • Afferent pupillary defect




    • Posterior ION




      • Bilateral visual loss or changes



      • Onset may be delayed a few days



      • Afferent pupillary defect or nonreactive pupil




    • Cortical blindness




      • Normal pupillary response and fundoscopic examination results



      • Occipital infarction on MRI




    • Acute closed-angle glaucoma




      • Presents as ocular pain and blurred vision with a red eye



      • Raised intraocular pressure (IOP)



      • Fixed, dilated pupil




    Similar Events





    • Residual petroleum-based ophthalmic ointment



    • Corneal abrasion



    • Photophobia



    • Residual anticholinergic medication effects



    • Glycine toxicity during TURP



    Management





    • Examine the patient and evaluate the severity of visual impairment or ocular trauma




      • Check visual fields



      • Check pupillary responses to light




    • If examination is abnormal, obtain urgent ophthalmologic consultation



    • Obtain MRI examination



    • Manage patient with ophthalmology




      • In the absence of a treatable cause, visual loss is likely to be permanent



      • The ASA Task Force on Perioperative Blindness found that there is no role for antiplatelet agents, steroids, or IOP-lowering agents in the treatment of ION




    • The following therapies have been attempted, but efficacy has not been proved.




      • Head-up position



      • Hyperbaric O 2



      • Augmenting O 2 delivery (optimization of BP, hematocrit, and arterial oxygenation)



      • Acetazolamide to lower IOP



      • Diuretics



      • Steroids



      • Anterior chamber paracentesis



      • Ocular massage to lower IOP and possibly dislodge emboli



      • Inhaled CO 2 in O 2 to enhance retinal artery dilation



      • Endovascular fibrinolysis of the ophthalmic artery for retinal artery occlusion



      • Optic nerve sheath decompression




    Complications


    Partial or total permanent visual loss


    Suggested Reading


  • 1. Roth S.: Perioperative visual loss: what do we know, what can we do?. Br J Anaesth 2009; 103: pp. i31-i40.
  • 2. Practice advisory for perioperative visual loss associated with spine surgery: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Visual Loss. Anesthesiology 2012; 116: pp. 274-285.
  • 3. Lee L.A., Roth S., Posner K.L., et. al.: The American Society of Anesthesiologists Postoperative Visual Loss Registry: analysis of 93 spine surgery cases with postoperative visual loss. Anesthesiology 2006; 105: pp. 652.
  • Only gold members can continue reading. Log In or Register to continue

    Stay updated, free articles. Join our Telegram channel

    Feb 22, 2019 | Posted by in ANESTHESIA | Comments Off on Neurologic Events

    Full access? Get Clinical Tree

    Get Clinical Tree app for offline access